SCHEDULE 13D/A

Beneficial Ownership Report

ORAMED PHARMACEUTICALS INC. Filed 2026-06-17 Acc 0001213900-26-069783

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-07-22 SCHEDULE 13D/A Beneficial Ownership Report
2026-06-17 SCHEDULE 13D/A Beneficial Ownership Report
2026-02-19 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

External

SEC EDGAR (opens in new tab)